Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChurchill China Regulatory News (CHH)

Share Price Information for Churchill China (CHH)

Share Price is delayed by 15 minutes
Get Live Data
340.00    0.00 (0.00%)
Bid:
330.00
Ask:
350.00
Spread: 20.00 (6.061%)
Market Cap: £37.39m
CHH Live PriceLast checked at - London Stock Exchange

Intraday Churchill China Share Chart

Trading Update

17 Jul 2025 07:00

RNS Number : 3899R
Churchill China PLC
17 July 2025
 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

17 July 2025

Churchill China plc

("Churchill China" or the "Company")

Trading Update

 

Churchill China plc (AIM: CHH), the manufacturer of innovative performance ceramic products serving hospitality markets worldwide, announces an update on trading in the current financial year ending 31 December 2025.

As communicated at the AGM, hospitality markets remain challenging with reduced demand for our product, particularly in export. Following a late Easter, April performance was broadly in line, however, the financial performance in May and particularly June was materially below target, meaning that the Company will deliver profitability significantly below last year at the half year. Whilst UK and USA sales have been robust, European and Rest of the World sales are tracking behind last year. The German market, in particular, has been difficult. We have also experienced trading down from our more expensive non-round pressure cast product into our own lower priced round product. We continue to be the supplier of choice into our distributor network, but it is the restaurants, particularly the independents, where cost pressures are creating market contraction, new installation projects remaining at lower levels, and increased competitive intensity. Replacement business remains at expected levels from the extensive installed base.

The Company has reduced hospitality production in line with the new demand profiles, but this has naturally resulted in lower factory recoveries in addition to the reduced margin due to sales mix.

Outlook

Despite the end user weakness, the Company believes that it continues to defend market share in its key markets. Capital projects initiated in the first half, focussed on increasing agility and improving our cost base are now broadly complete. We have also identified capital projects to pull forward to further reduce our cost structure. New product introductions, utilising inkjet and pressure cast, are being accelerated to restore growth exploiting our investment in these processes. We continue to review our cost base on an ongoing basis whilst being mindful of retaining skills required for growth.

Even with these actions, the continued market headwinds noted above mean that the Company will deliver revenue and profits for the full year significantly below the prior year.

We continue to prioritise a healthy cash balance which we intend to retain. We expect our markets to recover in the medium term and see no change to the long-term potential of the business.

We remain a well invested business in structured markets with a high percentage of our revenue originating from replacement orders at good margins.

The Company will issue its results for the six months ended 30 June 2025 in early September 2025.

 

For further information, please contact:

Churchill China plc

Tel: 01782 577566

David O'Connor / James Roper / Michael Cunningham

Burson Buchanan

Tel: 020 7466 5000

Mark Court / Sophie Wills / Abby Gilchrist

churchillchina@buchanan.uk.com

Investec Bank plc (Nominated Adviser and Joint Broker)

Tel: 020 7597 5970

David Flin / Oliver Cardigan

Panmure Liberum Limited (Joint Broker)

Tel: 020 3100 2000

Edward Thomas / John More

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFMESMEISEEW
Date   Source Headline
27th Mar 20249:30 amRNSNotification of Final Results
30th Jan 20244:41 pmRNSNotification of Major Holdings
30th Jan 202412:18 pmRNSNotification of Major Holdings
17th Jan 20247:00 amRNSFull Year Trading Update
16th Jan 20243:00 pmRNSAppointment of Non-Executive Director
27th Nov 20233:54 pmRNSNotification of Major Holdings
25th Sep 202310:18 amRNSNotification of Major Holdings
14th Sep 20237:00 amRNSInterim Results
17th Jul 20237:00 amRNSHalf Year Trading Update and Results Notification
22nd Jun 20236:20 pmRNSGrant of Options under LTIP
14th Jun 20232:06 pmRNSDirector/PDMR Shareholding
13th Jun 20233:32 pmRNSDirector/PDMR Shareholding
8th Jun 20235:11 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
19th May 20234:03 pmRNSNotification of Major Holdings
12th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
21st Apr 20239:28 amRNSNotification of Major Holdings
13th Apr 20237:00 amRNSDirectorate and Company Secretary Update
13th Apr 20237:00 amRNSFinal Results 2022
4th Apr 20237:00 amRNSNotification of Final Results
15th Feb 20237:00 amRNSAppointment of Independent Non-Executive Director
10th Jan 20237:00 amRNSFull Year Trading Update
20th Dec 20227:00 amRNSCFO Appointment
13th Dec 20227:00 amRNSFinance Director and Company Secretary Succession
14th Nov 20227:00 amRNSHolding(s) in Company
11th Oct 20229:55 amRNSAppointment of Non-Executive Director
16th Sep 20222:35 pmRNSDividend Payment Date Update
13th Sep 20227:00 amRNSInterim Results
30th Aug 20223:01 pmRNSInterim Results Analyst Meeting
18th Jul 202210:06 amRNSInterim Results Notification and Half Year Update
30th Jun 202210:27 amRNSNotification of Transaction of PCA
29th Jun 20227:00 amRNSGrant of Options under LTIP
27th Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 20224:00 pmRNSResult of AGM
22nd Jun 20227:00 amRNSAGM Statement
16th Jun 20224:44 pmRNSHolding(s) in Company
14th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
19th May 202211:22 amRNSBoard change and Annual Report & Accounts
21st Apr 20224:13 pmRNSDividend Record Date Correction
21st Apr 20227:00 amRNSPreliminary Results
4th Apr 20225:30 pmRNSHolding(s) in Company
31st Mar 202211:30 amRNSNotice of Preliminary Results
25th Mar 20227:56 amRNSHolding(s) in Company
23rd Mar 202212:27 pmRNSHolding(s) in Company
3rd Feb 20225:50 pmRNSHolding(s) in Company
31st Jan 20224:22 pmRNSHolding(s) in Company
28th Jan 20221:04 pmRNSHolding(s) in Company
19th Jan 20224:38 pmRNSHolding(s) in Company
7th Jan 20227:00 amRNSFull Year Trading Update
30th Dec 20213:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.